We assume that consecutive rounds of replication stress are a strong driver of CIN and not only do they repair deficiency, but endogenous replication stress could make TNBC cell lines eligible for PARP1 treatment. Here, PARP1 is linked to cervical squamous intraepithelial neoplasia.